{"id":"https://openalex.org/W2567069207","doi":"https://doi.org/10.2217/ebo.13.317","title":"Novel agents in development and future directions","display_name":"Novel agents in development and future directions","publication_year":2013,"publication_date":"2013-08-01","ids":{"openalex":"https://openalex.org/W2567069207","doi":"https://doi.org/10.2217/ebo.13.317","mag":"2567069207"},"language":"en","primary_location":{"id":"doi:10.2217/ebo.13.317","doi":"https://doi.org/10.2217/ebo.13.317","is_oa":false,"landing_page_url":"https://doi.org/10.2217/ebo.13.317","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Personalized Management of Lung Cancer","raw_type":"other"},"volume":{"id":"https://openalex.org/W2489304064","display_name":"Personalized Management of Lung Cancer"},"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102964486","display_name":"George R. Simon","orcid":"https://orcid.org/0000-0002-3894-0773","observed_orcids":["https://orcid.org/0000-0002-3894-0773"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"George R Simon","raw_affiliation_strings":["George R Simon is Professor of Medicine and Section Chief for Translational Research at the Department of Thoracic/Head and Neck Medical Oncology, University of Texas, MD Anderson Cancer Center, USA. His research interests include the prognostic and predictive functions of DNA repair genes in lung cancer. He is also interested in novel targeted therapies and how this can be optimally integrated in to patient care"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"George R Simon is Professor of Medicine and Section Chief for Translational Research at the Department of Thoracic/Head and Neck Medical Oncology, University of Texas, MD Anderson Cancer Center, USA. His research interests include the prognostic and predictive functions of DNA repair genes in lung cancer. He is also interested in novel targeted therapies and how this can be optimally integrated in to patient care","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5102964486"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"214","last_page":"235"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.7129999995231628},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.7609999775886536},{"id":"https://openalex.org/keywords/alk-inhibitors","display_name":"ALK inhibitors","score":0.7910000085830688},{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":0.9039999842643738},{"id":"https://openalex.org/keywords/pi3k-akt-inhibitors","display_name":"PI3K/AKT inhibitors","score":0.9900000095367432},{"id":"https://openalex.org/keywords/mapk-inhibitors","display_name":"MAPK inhibitors","score":0.8090000152587891},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.9589999914169312},{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":1.0},{"id":"https://openalex.org/keywords/fgfr-inhibitors","display_name":"FGFR inhibitors","score":0.8529999852180481},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hsp90-inhibitors","display_name":"Hsp90 inhibitors","score":0.9020000100135803},{"id":"https://openalex.org/keywords/immunomodulating-agents","display_name":"immunomodulating agents","score":0.8899999856948853},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.5920000076293945}],"concepts":[{"id":"https://openalex.org/C2776542497","wikidata":"https://www.wikidata.org/wiki/Q5266672","display_name":"Development (topology)","level":2,"score":0.6247110366821289},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.4242444932460785},{"id":"https://openalex.org/C2522767166","wikidata":"https://www.wikidata.org/wiki/Q2374463","display_name":"Data science","level":1,"score":0.3454239070415497},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.10963460803031921},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2217/ebo.13.317","doi":"https://doi.org/10.2217/ebo.13.317","is_oa":false,"landing_page_url":"https://doi.org/10.2217/ebo.13.317","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Personalized Management of Lung Cancer","raw_type":"other"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W130099911","https://openalex.org/W1542117945","https://openalex.org/W1600034671","https://openalex.org/W1819015028","https://openalex.org/W1968109047","https://openalex.org/W1969525589","https://openalex.org/W1970177198","https://openalex.org/W1976211156","https://openalex.org/W1977267072","https://openalex.org/W1977943009","https://openalex.org/W1978335582","https://openalex.org/W1980448975","https://openalex.org/W1987005520","https://openalex.org/W1997533142","https://openalex.org/W1999659306","https://openalex.org/W2019711215","https://openalex.org/W2023241927","https://openalex.org/W2036254130","https://openalex.org/W2043696829","https://openalex.org/W2048305487","https://openalex.org/W2055402151","https://openalex.org/W2060902443","https://openalex.org/W2065799563","https://openalex.org/W2070732456","https://openalex.org/W2075204007","https://openalex.org/W2077478539","https://openalex.org/W2080719056","https://openalex.org/W2086038769","https://openalex.org/W2098161852","https://openalex.org/W2098414192","https://openalex.org/W2101653483","https://openalex.org/W2106915761","https://openalex.org/W2107270715","https://openalex.org/W2114331359","https://openalex.org/W2114572046","https://openalex.org/W2129172946","https://openalex.org/W2139110945","https://openalex.org/W2144401692","https://openalex.org/W2155599713","https://openalex.org/W2159370421","https://openalex.org/W2159480044","https://openalex.org/W2160834915","https://openalex.org/W2163188200","https://openalex.org/W2171972386","https://openalex.org/W2275877493","https://openalex.org/W2330934614","https://openalex.org/W2748693890"],"related_works":["https://openalex.org/W2566495052","https://openalex.org/W1968560267","https://openalex.org/W2011462975","https://openalex.org/W2044926114","https://openalex.org/W2075204007","https://openalex.org/W3203726643","https://openalex.org/W2069719383","https://openalex.org/W2168959119","https://openalex.org/W2323562329","https://openalex.org/W2017531731"],"abstract_inverted_index":{"The":[0,195],"pace":[1],"of":[2,23,32,38,78,98,107,117,132,148,168,170,176,190,192,199,208],"finding":[3],"new":[4],"actionable":[5],"targets":[6],"has":[7,19],"increased":[8],"dramatically":[9],"in":[10,29,45,49,61,63,86,95,110,142,173,212],"the":[11,39,79,133,161,174,187,200,210],"last":[12],"few":[13],"years.":[14],"Along":[15],"with":[16],"this,":[17],"there":[18],"been":[20],"an":[21,76],"explosion":[22],"novel":[24,105],"targeted":[25],"agents":[26,108,172,201],"that":[27,41,185],"are":[28,42,47,59,71,94,102,137,202],"various":[30,96],"phases":[31],"preclinical":[33],"and":[34,56,69,101,127,153],"clinical":[35,88,99],"development.":[36],"Some":[37],"compounds":[40],"farthest":[43],"along":[44],"development":[46,100,191],"discussed":[48,60,73,109],"this":[50,111,143],"chapter.":[51],"EGF":[52],"receptor":[53,125,150],"(EGFR)":[54],"inhibitors":[55,58,93,116,152],"angiogenesis":[57],"detail":[62],"Chapters":[64],"11":[65],"&":[66],"12,":[67],"respectively,":[68],"hence":[70],"not":[72],"here.":[74],"Crizotinib,":[75],"inhibitor":[77],"anaplastic":[80],"lymphoma":[81],"kinase":[82],"(ALK),":[83],"is":[84,145,158,182,215],"now":[85],"common":[87],"practice.":[89],"Several":[90],"other":[91],"ALK":[92],"stages":[97],"discussed.":[103,139],"Other":[104],"categories":[106],"chapter":[112,144],"include,":[113],"immunomodulating":[114],"agents,":[115],"C-MET/HGF,":[118],"PI3K/Akt,":[119],"MAPK/MAP/ERK,":[120],"Braf,":[121],"Src/STAT,":[122],"mTOR,":[123],"FGF":[124],"(FGFR)":[126],"poly(ADP-ribose)":[128],"polymerase":[129],"(PARP).":[130],"Inhibitors":[131],"heat-shock":[134],"protein-90":[135],"(HSP-90)":[136],"also":[138],"Conspicuously":[140],"absent":[141],"a":[146,166,183],"discussion":[147],"IGF":[149],"(IGFR)":[151],"vascular":[154],"disrupting":[155],"agents.":[156],"This":[157],"deliberate,":[159],"given":[160],"recent":[162],"published":[163],"reports":[164],"showing":[165],"lack":[167],"efficacy":[169],"these":[171,193],"treatment":[175],"lung":[177],"cancer.":[178],"Under":[179],"each":[180,213],"section":[181,214],"description":[184],"outlines":[186],"current":[188],"status":[189],"compounds.":[194],"class":[196],"effect":[197],"toxicities":[198],"discussed,":[203],"if":[204],"known.":[205],"For":[206],"ease":[207],"reference,":[209],"information":[211],"tabulated.":[216]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2017-01-06T00:00:00"}